The content is available as a PDF (366.2 KB).
editorial . 2021 Mar 23:ciab259. doi: 10.1093/cid/ciab259
COVID-19 Associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes?
John W Baddley
1,✉
John W Baddley, MD, MSPH
1
University of Maryland School of Medicine and Baltimore VA Medical Center, Baltimore, MD
Find articles by John W Baddley
1
University of Maryland School of Medicine and Baltimore VA Medical Center, Baltimore, MD
✉
Corresponding Author: John W. Baddley, MD, MSPH, University of Maryland School of Medicine, Division of Infectious Diseases, Institute of Human Virology , 725 West Lombard Street, Baltimore, MD 21201, 410-706-6444, F410-706-1992, jbaddley@ihv.umaryland.edu
Received 2021 Mar 16.
Keywords: Aspergillosis, COVID-19, CAPA, Aspergillus
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
PMCID: PMC8083609 PMID: 33754152
See commentary "COVID-19 Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients", ciab223.